quinpirole has been researched along with Bradykinesia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bernardi, G; Calabresi, P; Costa, C; Goldberg, MS; Haburcak, M; Kitada, T; Martella, G; Martins, A; Pisani, A; Pothos, EN; Roth, BL; Shen, J; Tong, Y; Tscherter, A; Vortherms, TA | 1 |
1 other study(ies) available for quinpirole and Bradykinesia
Article | Year |
---|---|
Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Age Factors; Animals; Behavior, Animal; Blotting, Southern; Blotting, Western; Cell Count; Cerebral Cortex; Disease Models, Animal; Dopamine; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Electric Stimulation; Electrochemistry; Excitatory Postsynaptic Potentials; Germ-Line Mutation; Humans; Hypokinesia; Immunohistochemistry; In Vitro Techniques; Intracellular Signaling Peptides and Proteins; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nerve Tissue Proteins; Neurons; Oncogene Proteins; Parkinsonian Disorders; Protein Deglycase DJ-1; Quinpirole; Radioligand Assay; Receptors, Dopamine D2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Substantia Nigra; Tyrosine 3-Monooxygenase | 2005 |